NCT00376948View on ClinicalTrials.gov

Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Pancreatic Cancer
Interventions
DIETARY_SUPPLEMENT

genistein

DRUG

erlotinib hydrochloride

DRUG

gemcitabine hydrochloride

Trial Locations (2)

48201-1379

Barbara Ann Karmanos Cancer Institute, Detroit

77030-4009

M. D. Anderson Cancer Center at University of Texas, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Barbara Ann Karmanos Cancer Institute

OTHER

NCT00376948 - Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | Biotech Hunter | Biotech Hunter